Vyloy is the first CLDN18.2-targeting drug to reach the US market but has already been approved in Japan as well as in the EU ...

Promising results from the anti–LAG-3/anti–PD-1 combo for melanoma, FDA approval of inavolisib for PIK3CA-mutant breast cancer, significant survival benefits from talazoparib and enzalutamide in ...

Young adults who develop colon cancer tend to be diagnosed at later stages of the devastating disease – and have more aggressive types of tumours, new research has found.

Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved ...

The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the ...

Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of malignant ascites in adults with epithelial cell adhesion ...

Cancer is a leading cause of death among Hispanic people in the U.S., according to the American Cancer Society. Compared to ...

NHS patients will reportedly be given wearable technology that tracks blood pressure and glucose spikes. It may also monitor ...

Certain supplements have been shown to help with muscle growth, strength, and overall athletic performance—including ...

Staring in the face of a two-loss weekend, the Bemidji State women’s soccer team got an equalizer from an unlikely freshman.

Delhiites, who have been exposed to air pollution for years now, are not only at a higher risk of respiratory but also cardiac, neurological and gastric ... cases of lung cancer were due to smoking, ...

I'm 75, and since I had a tumour removed from my prostate I've suffered with erectile dysfunction and incontinence. Nothing ...